Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis [Phase 3]
Phase 3 trial results show that Fingolimod (FTY720) demonstrated efficacy and acceptable safety in relapsing-remitting multiple sclerosis, w…
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment
A completed clinical trial evaluating whether serum leptin levels correlate with multiple sclerosis disease activity in patients treated wit…
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: A Randomized Exercise Trial for Wheelchair Users [NA]
A completed randomized exercise trial for wheelchair users evaluating outcomes across conditions such as spinal cord injury and multiple scl…
-
CLINICAL_TRIALS withdrawal · 2012-06-14Clinical Trial Update: Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. [Phase 2]
A Phase 2 trial investigating immunoregulation by controlled parasite exposure in multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome [Phase 3]
Phase 3 trial evaluating early treatment with glatiramer acetate to delay conversion from clinically isolated syndrome to clinically definit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Memantine Therapy for Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating memantine for multiple sclerosis has been terminated. Sponsored by Clinica Universidad de Navarra and Un…
-
CLINICAL_TRIALS research · 2012-05-30Clinical Trial Update: Physical Activity and Fatigue in Early Multiple Sclerosis (MS)
Bayer-sponsored trial evaluating physical activity and fatigue in early multiple sclerosis has completed, marking an end to the study.
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients [Phase 3]
A Phase 3 trial evaluating cranberry supplementation to prevent urinary tract infections in patients with multiple sclerosis has completed.
-
FDA approval · 2012-05-09FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod HCl) submitted by Novartis Pharmaceuticals Corporation to modify the pro…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Cognitive Testing for the Pain Quality Assessment Scale (PQAS)
This entry notes a completed clinical trial evaluating cognitive testing for the Pain Quality Assessment Scale (PQAS). It relates to pain co…
-
CLINICAL_TRIALS research · 2012-05-08Clinical Trial Update: Venous Irregularities, Flow and Perfusion in MS Study
A clinical trial studying venous irregularities, flow and perfusion in people with multiple sclerosis and non-MS participants. The current s…
-
CLINICAL_TRIALS research · 2012-05-03Clinical Trial Update: Psychometric Validation of Cognitive Endpoints
This clinical trial update reports the completed psychometric validation of cognitive endpoints for multiple sclerosis, evaluating the relia…
-
EMA guidance · 2012-04-20European Medicines Agency gives new advice to better manage risk of adverse effects on the heart with Gilenya
EMA provides new guidance to better manage the risk of heart-related adverse effects with Gilenya (fingolimod).
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS) [Phase 2]
A Phase 2 trial comparing SB-683699 to placebo in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Cognitive Effects of Immunomodulatory Drugs in MS
This clinical trial update examines the cognitive effects of immunomodulatory drugs in people with multiple sclerosis. The study status is l…
-
FDA approval · 2012-03-18FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for GILENYA (fingolimod HCl) submitted by Novartis Pharmaceuticals Corporation. The document indicat…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Study To Evaluate Treating Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis Patients [NA]
The clinical trial evaluating treatment for chronic cerebrospinal venous insufficiency in multiple sclerosis patients was terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis [NA]
A completed clinical trial evaluated a herbal therapy to treat injection-site reactions in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: BENEFIT Extension Study
The BENEFIT Extension Study in multiple sclerosis has completed, offering additional follow-up data from the original trial.
-
CLINICAL_TRIALS research · 2012-03-05Clinical Trial Update: A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
This document reports on a prospective clinical study investigating spasticity in individuals with multiple sclerosis; the current trial sta…
-
FDA approval · 2012-03-01FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod HCl) submitted by Novartis Pharmaceuticals Corporation, updating the pro…
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
A completed clinical trial update detailing pharmacokinetic, immunological, and biochemical sample collection and analysis in a natalizumab-…
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis [Phase 3]
Open-label extension study evaluating safety, tolerability, and activity of oral fampridine-SR in patients with multiple sclerosis; the tria…
-
FDA approval · 2012-02-27FDA Approved: AVONEX — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for AVONEX (interferon beta-1a). This action approves a supplemental submission to modify…
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial [Phase 3]
Open-label extension study assessing safety, tolerability, and activity of oral fampridine-SR in multiple sclerosis patients who previously …